Acorah Software Products - Accounts Production 16.1.300 false true 30 June 2023 8 June 2022 false true No description of principal activity 1 July 2023 30 June 2024 30 June 2024 14158931 Mr Kashminder Raju iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14158931 2023-06-30 14158931 2024-06-30 14158931 2023-07-01 2024-06-30 14158931 frs-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 14158931 frs-bus:FilletedAccounts 2023-07-01 2024-06-30 14158931 frs-bus:Micro-entities 2023-07-01 2024-06-30 14158931 frs-bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 14158931 frs-bus:Director1 2023-07-01 2024-06-30 14158931 2022-06-07 14158931 2023-06-30 14158931 2022-06-08 2023-06-30
Pavelle Limited
Financial Statements
For The Year Ended 30 June 2024
Balance Sheet
Registered number: 14158931
30 June 2024 30 June 2023
£ £
Current assets 100 100
NET CURRENT ASSETS 100 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100 100
NET ASSETS 100 100
CAPITAL AND RESERVES 100 100

Notes

1. General Information
Pavelle Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14158931 . The registered office is Unit 6 Heritage Business Centre, Derby Road, Belper, Derbyshire, DE56 1SW.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: )
- -
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Kashminder Raju
Director
6 March 2025